TY - JOUR
T1 - EDITOR SPOTLIGHT
T2 - Interview with Cholinergic Mechanisms Special Issue Guest Editor Hermona Soreq
AU - JNC Editorial Office
AU - Kwan, Kim H.
AU - Soreq, Hermona
N1 - Publisher Copyright:
© 2024 International Society for Neurochemistry.
PY - 2024/4
Y1 - 2024/4
N2 - Hermona Soreq holds a Hebrew University Slesinger Chair in Molecular Neuroscience and is among the founding members of the Edmond and Lily Safra Center of Brain Sciences (ELSC). Soreq's research (H-impact: 98) focuses on acetylcholine (ACh)-related pathways and combines RNA-sequencing technologies, transgenic engineering, and molecular biology tests with in-depth analysis approaches. Her work addresses microRNAs (miRs) and transfer RNA fragments (tRFs) which have rapidly acquired wide recognition as global controllers of regulatory processes in healthy and diseased brain and body, including anxiety, inflammation, and cognition. Altogether, Soreq's work leads to molecular neuroscience-driven prevention and/or intervention with diseases involving impaired ACh signaling, including schizophrenia, bipolar disorder, Alzheimer's disease, and stress. Hermona led this Special Issue based on the 17th Symposium on Cholinergic Mechanisms (ISCM2022). We interviewed her on the progress in the field, what she wants to achieve as Senior Editor for the Gene Regulation and Genetics category at the Journal of Neurochemistry, key moments, and future directions.
AB - Hermona Soreq holds a Hebrew University Slesinger Chair in Molecular Neuroscience and is among the founding members of the Edmond and Lily Safra Center of Brain Sciences (ELSC). Soreq's research (H-impact: 98) focuses on acetylcholine (ACh)-related pathways and combines RNA-sequencing technologies, transgenic engineering, and molecular biology tests with in-depth analysis approaches. Her work addresses microRNAs (miRs) and transfer RNA fragments (tRFs) which have rapidly acquired wide recognition as global controllers of regulatory processes in healthy and diseased brain and body, including anxiety, inflammation, and cognition. Altogether, Soreq's work leads to molecular neuroscience-driven prevention and/or intervention with diseases involving impaired ACh signaling, including schizophrenia, bipolar disorder, Alzheimer's disease, and stress. Hermona led this Special Issue based on the 17th Symposium on Cholinergic Mechanisms (ISCM2022). We interviewed her on the progress in the field, what she wants to achieve as Senior Editor for the Gene Regulation and Genetics category at the Journal of Neurochemistry, key moments, and future directions.
KW - acetylcholine
KW - cholinergic
KW - neurochemistry
UR - http://www.scopus.com/inward/record.url?scp=85188549391&partnerID=8YFLogxK
U2 - 10.1111/jnc.16096
DO - 10.1111/jnc.16096
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???
C2 - 38491750
AN - SCOPUS:85188549391
SN - 0022-3042
VL - 168
SP - 331
EP - 333
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 4
ER -